Literature DB >> 14630152

Protein and antibody microarray technology.

Jörn Glökler1, Philipp Angenendt.   

Abstract

Following the age of genomics having sequenced the human genome, interest is shifted towards the function of genes. This new age of proteomics brings about a change of methods to study the properties of gene products on a large scale. Protein separation technologies are now applied to allow high-throughput purification and characterisation of proteins. Two-dimensional-gel electrophoresis (2DE) and mass spectrometry (MS) have become widely used tools in the field of proteomics. At the same time, protein and antibody microarrays have been developed as successor of DNA microarrays to soon allow the proteome-wide screening of protein function in parallel. This review is aimed to introduce this new technology and to highlight its current prospects and limitations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630152     DOI: 10.1016/j.jchromb.2003.08.034

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  18 in total

1.  Fabrication of a gel particle array in a microfluidic device for bioassays of protein and glucose in human urine samples.

Authors:  Ling Lin; Zhaoxin Gao; Huibin Wei; Haifang Li; Feng Wang; Jin-Ming Lin
Journal:  Biomicrofluidics       Date:  2011-08-08       Impact factor: 2.800

Review 2.  [Microarray technique for component resolved diagnosis (CRD) in type-I allergies. An innovative technology at the border between research tool and routine diagnostics].

Authors:  L Klimek; D Vetter; L von Bernus; C Thorn
Journal:  HNO       Date:  2011-10       Impact factor: 1.284

3.  Comparison of hydroxylated print additives on antibody microarray performance.

Authors:  Peng Wu; David W Grainger
Journal:  J Proteome Res       Date:  2006-11       Impact factor: 4.466

4.  Microarray methods for protein biomarker detection.

Authors:  Hye Jin Lee; Alastair W Wark; Robert M Corn
Journal:  Analyst       Date:  2008-06-05       Impact factor: 4.616

Review 5.  Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs.

Authors:  Robert E Gerszten; Frank Accurso; Gordon R Bernard; Richard M Caprioli; Eric W Klee; George G Klee; Iftikhar Kullo; Theresa A Laguna; Frederick P Roth; Marc Sabatine; Pothur Srinivas; Thomas J Wang; Lorraine B Ware
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

Review 6.  Other notable protein blotting methods: a brief review.

Authors:  Biji T Kurien; R Hal Scofield
Journal:  Methods Mol Biol       Date:  2015

7.  Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX™: planar microarray diagnosis.

Authors:  Peter Lea; Edward Keystone; Sasi Mudumba; Anthony Kahama; Shi-Fa Ding; Jennifer Hansen; Azar A Azad; Sihe Wang; Deborah Weber
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

8.  Application of photonic crystal enhanced fluorescence to cancer biomarker microarrays.

Authors:  Cheng-Sheng Huang; Sherine George; Meng Lu; Vikram Chaudhery; Ruimin Tan; Richard C Zangar; Brian T Cunningham
Journal:  Anal Chem       Date:  2011-01-21       Impact factor: 6.986

9.  Sensing lectin-glycan interactions using lectin super-microarrays and glycans labeled with dye-doped silica nanoparticles.

Authors:  Xin Wang; Elena Matei; Lingquan Deng; Leonardus Koharudin; Angela M Gronenborn; Olof Ramström; Mingdi Yan
Journal:  Biosens Bioelectron       Date:  2013-03-21       Impact factor: 10.618

Review 10.  Antibody-based protein multiplex platforms: technical and operational challenges.

Authors:  Allison A Ellington; Iftikhar J Kullo; Kent R Bailey; George G Klee
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.